Kyle J. Norton
Black or common beans may be considered as function foods in attenuated risk of cardiovascular disease, a renowned institute postulated.
Cardiovascular disease is a condition of heart attack caused by a block of blood in vessels as a result of the narrowing and hardening of blood vessels.
Black bean, a small roughly ovoid legumes with glossy black shells, genus Phaseolus, belongings to the family Fabaceae can be bought in most grocery stores all around the year in dried and canned forms.
It is believed that the black bean was the first domesticated growth in South America.
According to the University of Colorado Colorado Springs, individuals who eat more beans in promoted less glycaemic stress (hyperglycemia and hyperinsulinemia) may have a reduced risk of CVD,
The study also addressed the importance of bean efficacy on glycaemic response and the impact that relationship may have on the risk of developing diabetes and CVD.
In the Sprague-Dawley rats model and C57Bl/6 mice induced obesity by a diet, both bean diet, groups showed a significant in reduced plasma total cholesterol and LDL-cholesterol without affecting HDL-cholesterol or total TAG in the short-term. And bean-fed obese mice not only induced weight loss but also improved plasma lipid profile within a 12 d time frame compared to other groups.
The weight loss and reduced levels of blood cholesterol in tested subjects provided significant information on bean function in ameliorated risk of cardiovascular disease.
Other in the study of the risk of development of cardiovascular complications in patients with diabetes, suggested that the imbalance between reactive oxygen species and antioxidant systems in patients with type 2 diabetes may be the leading cause of heart complications involving high cardiac collagen content.
Therefore, increased intake of bean diet may play a prevalent role in reduced risk of CVD by increased total antioxidant activity and decreased the expression of hyperglycaemic state, catalase and superoxide dismutase activity, and tissue damage caused by lipid peroxidation.
Dr. Oliveira RJ, the lead author said, "The phaseolamin treatment attenuated the collagen levels compared to non-treated diabetic rats. Thus, the short-term anti-hyperglycaemic effect of the phaseolamin treatment may prevent the initial changes caused by oxidative stress and the deposition of collagen, as well as reduce the incidence of heart complications".
Collectively, adding a bean portion to your diet daily may have a substantially reduced risk of heart disease and heart complications in diabetics, in comparison to people with a typical American diet.
Natural Medicine for Fatty Liver And Obesity Reversal - The Revolutionary Findings To Achieve Optimal Health And Loose Weight
Ovarian Cysts And PCOS Elimination
Holistic System In Existence That Will Show You How To
Permanently Eliminate All Types of Ovarian Cysts Within 2 Months
Back to Kyle J. Norton's Home page http://kylejnorton.blogspot.ca
Author Biography
Kyle J. Norton(Scholar, Master of Nutrients), all right reserved.
Health article writer and researcher; Over 10.000 articles and research papers have been written and published online, including worldwide health, ezine articles, article base, healthblogs, self-growth, best before it's news, the Karate GB Daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as the international journal Pharma and Bio Science, ISSN 0975-6299.
Sources
(1) Phaseolus beans: impact on glycaemic response and chronic disease risk in human subjects by Hutchins AM1, Winham DM, Thompson SV. (PubMed)
(2) Edible dry bean consumption (Phaseolus vulgaris L.) modulates cardiovascular risk factors and diet-induced obesity in rats and mice by Zhu Z1, Jiang W, Thompson HJ. (PubMed)
(3) Phaseolamin treatment prevents oxidative stress and collagen deposition in the hearts of streptozotocin-induced diabetic rats by Oliveira RJ1, de Oliveira VN, Deconte SR, Calábria LK, da Silva Moraes A, Espindola FS. (PubMed)
No comments:
Post a Comment